EDGAR Filing Documents for 0001615774-16-004969

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001615774-16-004969

Filing Date

2016-04-14

Accepted

2016-04-14 17:24:44

Documents

Period of Report

2015-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	s103020_10k.htm	10-K	675910
2	EXHIBIT 10-44	s103020_ex10-44.htm	EX-10.44	73642
3	EXHIBIT 10-45	s103020_ex10-45.htm	EX-10.45	72467
4	EXHIBIT 31.1	s103020_31-1.htm	EX-31.1	10006
5	EXHIBIT 31.2	s103020_31-2.htm	EX-31.2	15235
6	EXHIBIT 32.1	s103020_32-1.htm	EX-32.1	5425
7	EXHIBIT 32.2	s103020_32-2.htm	EX-32.2	8364
8	GRAPHIC	tlogo.jpg	GRAPHIC	8195
	Complete submission text file	0001615774-16-004969.txt		5474172

Data Files

Seq	Description	Document	Type	Size
9	XBRL INSTANCE FILE	cttc-20151231.xml	EX-101.INS	923625
10	XBRL SCHEMA FILE	cttc-20151231.xsd	EX-101.SCH	64621
11	XBRL CALCULATION FILE	cttc-20151231_cal.xml	EX-101.CAL	63082
12	XBRL DEFINITION FILE	cttc-20151231_def.xml	EX-101.DEF	315899
13	XBRL LABEL FILE	cttc-20151231_lab.xml	EX-101.LAB	472146
14	XBRL PRESENTATION FILE	cttc-20151231_pre.xml	EX-101.PRE	390822

Mailing Address 1375 KINGS HIGHWAY EAST FAIRFIELD CT 06824

Business Address 1375 KINGS HIGHWAY EAST FAIRFIELD CT 06824 (203) 368-6044

CALMARE THERAPEUTICS Inc (Filer) CIK: 0000102198 (see all company filings)